金石亚药(300434.SZ)获得硫酸氨基葡萄糖胶囊药品注册证书

Core Viewpoint - Company Jinshi Yao (300434.SZ) has received approval from the National Medical Products Administration for its subsidiary Zhejiang Yake Pharmaceutical Co., Ltd. to market Glucosamine Sulfate Capsules, which are classified as non-prescription analgesics for osteoarthritis treatment [1] Group 1: Product Approval - The approval includes the issuance of a Drug Registration Certificate for Glucosamine Sulfate Capsules, which is considered equivalent to passing the consistency evaluation [1] - Glucosamine is a natural amino monosaccharide that serves as a precursor for the synthesis of proteoglycans, enhancing the repair capacity of chondrocytes [1] Group 2: Product Functionality - The capsules are indicated for primary and secondary osteoarthritis, helping to alleviate joint pain and improve joint function [1] - Glucosamine can inhibit enzymes that damage cartilage, such as collagenase and phospholipase A2, and prevent the production of superoxide free radicals that harm cells [1] - The product promotes the repair and reconstruction of cartilage matrix, potentially delaying the pathological process of osteoarthritis and improving patient outcomes [1]